SC
VTAE

Steven Cohen’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Steven Cohen’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-55,074
Closed -$594K – 946
2016
Q2 		$594K Sell
55,074
-419,926
-88% -$3.59M ﹤0.01% 651
2016
Q1 		$3.15M Buy
+475,000
New +$4.32M 0.02% 505
2015
Q4 		– Sell
-594,535
Closed -$6.55M – 951
2015
Q3 		$6.55M Buy
594,535
+149,693
+34% +$1.59M 0.05% 388
2015
Q2 		$6.41M Buy
444,842
+79,842
+22% +$1.08M 0.04% 410
2015
Q1 		$4.27M Buy
+365,000
New +$4.92M 0.03% 460

Other funds holding VTAE

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Steven Cohen's VTAE Position: Q3 2016 in Review

Steven Cohen sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2016, closing a stake of 55,074 shares — an estimated $594K sold.

Steven Cohen first reported a position in VTAE in Q1 2015 and held it in 5 quarters. The position peaked at $6.55M in Q3 2015. 98 funds tracked by Wall St. Rank hold VTAE as of Q3 2016.

  • Steven Cohen reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Steven Cohen sold 55,074 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2016, an estimated $594K.
  • Steven Cohen first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 5 quarters.
  • Steven Cohen's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $6.55M in Q3 2015.
  • 98 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2016.

Based on Point72 Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.